June 5, 2008 - MacroChem Corporation (OTC Bulletin Board: MACM) announced that Michael Zasloff, MD, PhD , Professor, Department of Surgery, Georgetown University, a pioneer in the discovery of antimicrobial peptides and a member of MacroChem's Scientific Advisory Board, will make a presentation entitled "Topical Therapy for Infections: Are Peptides Ready for Prime-Time?" at a symposium entitled New Developments in Diabetic Foot Wound Assessment and Treatment at the 68th Scientific Session of the American Diabetes Association in San Francisco on June 8, 2008 at 2:30 pm local time. Dr. Zasloff will discuss recent discoveries in innate immunity that explain the role of antimicrobial peptides in protecting human skin from infection. In this context, he will discuss the rationale for the development of a topical antimicrobial peptide for the treatment of infected diabetic foot ulcers. This condition remains a leading complication of diabetes, resulting in thousands of lower limb amputations yearly... MacroChem's Press Release -
